Contributors |
|
vi | |
Preface |
|
viii | |
Arterial diseases |
|
|
1 Lifestyle changes and risk factor modification |
|
|
3 | (8) |
|
|
|
2 Cilostazol and pentoxifylline in the treatment of peripheral arterial diseases |
|
|
11 | (10) |
|
Dinesh Arab and Leslie Cho |
|
|
|
|
21 | (26) |
|
Eron D Crouch and Steven R Steinhubl |
|
|
|
4 Lipid-modifying therapy |
|
|
47 | (18) |
|
Victor M Mejia and Herbert D Aronow |
|
|
|
5 Renin-angiotensin-aldosterone system (RAAS) blockade in peripheral arterial diseases |
|
|
65 | (10) |
|
Bertram Pitt, Debabrata Mukherjee and Sanjay Rajagopalan |
|
|
|
6 Beta-blockers in peripheral arterial disease |
|
|
75 | (6) |
|
Joel Reginelli and Stanley J Chetcuti |
|
|
|
7 Fibrinolytic therapy in peripheral arterial disease |
|
|
81 | (20) |
|
David S Lee and Deepak L Bhatt |
|
|
|
8 Antithrombotic therapies |
|
|
101 | (18) |
|
|
|
|
119 | (10) |
|
Juhana Karha and Samir R Kapadia |
|
|
|
10 Pharmacotherapy for global cardiovascular risk reduction |
|
|
129 | (10) |
|
Kim A Eagle and Debabrata Mukherjee |
|
|
Venous diseases |
|
|
11 Deep venous thrombosis/pulmonary embolism pharmacotherapy |
|
|
139 | (24) |
|
Douglas E Joseph and John R Bartholomew |
|
|
|
12 Compression therapy and injection sclerotherapy for venous disease |
|
|
163 | (20) |
|
Rupal Dumasia and John Pfeifer |
|
|
Index |
|
183 | |